Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

ABSTRACT: This research study is comparing two standard of care treatment options based on blood test results for participants who have metastatic colorectal cancer. The names of the potential treatments involved in this study are: * Active surveillance * FOLFIRI treatment * Nivolumab treatment * Encorafenib/Binimetinib/Cetuximab treatment

DISEASE(S): Metastatic Colorectal Cancer,Stage Iii Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2294315 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR